Home > News > New Clinical Trial with MagForce® Nano-Cancer Therapy
January 13th, 2006
New Clinical Trial with MagForce® Nano-Cancer Therapy
Abstract:
In January 2006 another clinical study was started on the MagForce® Nano-Cancer Therapy, this time enrolling patients suffering from metastasized esophageal cancer. This study is being performed at the Klinik für Chirurgie und Chirurgische Onkologie, Charité Berlin (Director: Prof. Dr. med. Peter M. Schlag) under the leadership of PD Dr. med. Beate Rau together with Dr. med. S. Koswig and Dr. med. P. Reichard. (PDF)
Source:
mag-force.de
| Related News Press |
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||